- Home
- TTGT vs LXRX Comparison
TTGT vs LXRX Comparison
Compare TTGT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TTGT | LXRX |
|---|---|---|
| Founded | 1999 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.9M | 447.0M |
| IPO Year | 2007 | 2000 |
Fundamental Metrics
Financial Performance| Metric | TTGT | LXRX |
|---|---|---|
| Price | $5.59 | $1.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $11.25 | $3.23 |
| AVG Volume (30 Days) | 362.2K | ★ 1.5M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $446,514,000.00 | $70,864,000.00 |
| Revenue This Year | $74.33 | $56.61 |
| Revenue Next Year | $3.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 71.55 | ★ 1255.21 |
| 52 Week Low | $4.63 | $0.28 |
| 52 Week High | $21.38 | $1.66 |
Technical Indicators
Market Signals| Indicator | TTGT | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.30 | 34.83 |
| Support Level | $5.13 | $1.29 |
| Resistance Level | $5.98 | $1.25 |
| Average True Range (ATR) | 0.37 | 0.08 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 69.29 | 12.33 |
Price Performance
Historical ComparisonAbout TTGT TechTarget Inc.
TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. Through its B2B first-party data and an end-to-end portfolio of data-driven solutions, it services the full B2B product lifecycle for customers from, messaging, and content development to in-market activation via brand, demand generation, purchase intent data, and sales enablement from R&D to ROI.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.